Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
Qu WF, Ding ZB, Qu XD, Tang Z, Zhu GQ, Fu XT, Zhang ZH, Zhang X, Huang A, Tang M, Tian MX, Jiang XF, Huang R, Tao CY, Fang Y, Gao J, Wu XL, Zhou J, Fan J, Liu WR, Shi YH.
Qu WF, et al. Among authors: liu wr.
BJS Open. 2022 Sep 2;6(5):zrac114. doi: 10.1093/bjsopen/zrac114.
BJS Open. 2022.
PMID: 36125345
Free PMC article.